Global Companion Diagnostic Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Companion Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Companion Diagnostic market size is estimated to be worth US$ 9075.3 million in 2021 and is forecast to a readjusted size of USD 31360 million by 2028 with a CAGR of 19.4% during review period. Oncology accounting for % of the Companion Diagnostic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunohistochemistry segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Companion Diagnostic include Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Companion Diagnostic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunohistochemistry
Molecular Diagnosis
Market segment by Application, can be divided into
Oncology
Cardiovascular
Central Nervous System
Virology
Others
Market segment by players, this report covers
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina, Inc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Companion Diagnostic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Companion Diagnostic, with revenue, gross margin and global market share of Companion Diagnostic from 2019 to 2022.
Chapter 3, the Companion Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Companion Diagnostic market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Companion Diagnostic research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Companion Diagnostic
1.2 Classification of Companion Diagnostic by Type
1.2.1 Overview: Global Companion Diagnostic Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Companion Diagnostic Revenue Market Share by Type in 2021
1.2.3 Immunohistochemistry
1.2.4 Molecular Diagnosis
1.3 Global Companion Diagnostic Market by Application
1.3.1 Overview: Global Companion Diagnostic Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Virology
1.3.6 Others
1.4 Global Companion Diagnostic Market Size & Forecast
1.5 Global Companion Diagnostic Market Size and Forecast by Region
1.5.1 Global Companion Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Companion Diagnostic Market Size by Region, (2017-2022)
1.5.3 North America Companion Diagnostic Market Size and Prospect (2017-2028)
1.5.4 Europe Companion Diagnostic Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Companion Diagnostic Market Size and Prospect (2017-2028)
1.5.6 South America Companion Diagnostic Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Companion Diagnostic Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Companion Diagnostic Market Drivers
1.6.2 Companion Diagnostic Market Restraints
1.6.3 Companion Diagnostic Trends Analysis
2 Company Profiles
2.1 Roche Holdings
2.1.1 Roche Holdings Details
2.1.2 Roche Holdings Major Business
2.1.3 Roche Holdings Companion Diagnostic Product and Solutions
2.1.4 Roche Holdings Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche Holdings Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Companion Diagnostic Product and Solutions
2.2.4 Abbott Laboratories Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Companion Diagnostic Product and Solutions
2.3.4 Thermo Fisher Scientific Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Companion Diagnostic Product and Solutions
2.4.4 Agilent Technologies Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Companion Diagnostic Product and Solutions
2.5.4 Merck Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Merck Recent Developments and Future Plans
2.6 Agendia
2.6.1 Agendia Details
2.6.2 Agendia Major Business
2.6.3 Agendia Companion Diagnostic Product and Solutions
2.6.4 Agendia Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Agendia Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Companion Diagnostic Product and Solutions
2.7.4 Qiagen Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 Myriad Genetics
2.8.1 Myriad Genetics Details
2.8.2 Myriad Genetics Major Business
2.8.3 Myriad Genetics Companion Diagnostic Product and Solutions
2.8.4 Myriad Genetics Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Myriad Genetics Recent Developments and Future Plans
2.9 Advanced Cell Diagnostics
2.9.1 Advanced Cell Diagnostics Details
2.9.2 Advanced Cell Diagnostics Major Business
2.9.3 Advanced Cell Diagnostics Companion Diagnostic Product and Solutions
2.9.4 Advanced Cell Diagnostics Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.10 Danaher
2.10.1 Danaher Details
2.10.2 Danaher Major Business
2.10.3 Danaher Companion Diagnostic Product and Solutions
2.10.4 Danaher Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Danaher Recent Developments and Future Plans
2.11 Illumina, Inc
2.11.1 Illumina, Inc Details
2.11.2 Illumina, Inc Major Business
2.11.3 Illumina, Inc Companion Diagnostic Product and Solutions
2.11.4 Illumina, Inc Companion Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Illumina, Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Companion Diagnostic Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Companion Diagnostic Players Market Share in 2021
3.2.2 Top 10 Companion Diagnostic Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Companion Diagnostic Players Head Office, Products and Services Provided
3.4 Companion Diagnostic Mergers & Acquisitions
3.5 Companion Diagnostic New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Companion Diagnostic Revenue and Market Share by Type (2017-2022)
4.2 Global Companion Diagnostic Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Companion Diagnostic Revenue Market Share by Application (2017-2022)
5.2 Global Companion Diagnostic Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Companion Diagnostic Revenue by Type (2017-2028)
6.2 North America Companion Diagnostic Revenue by Application (2017-2028)
6.3 North America Companion Diagnostic Market Size by Country
6.3.1 North America Companion Diagnostic Revenue by Country (2017-2028)
6.3.2 United States Companion Diagnostic Market Size and Forecast (2017-2028)
6.3.3 Canada Companion Diagnostic Market Size and Forecast (2017-2028)
6.3.4 Mexico Companion Diagnostic Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Companion Diagnostic Revenue by Type (2017-2028)
7.2 Europe Companion Diagnostic Revenue by Application (2017-2028)
7.3 Europe Companion Diagnostic Market Size by Country
7.3.1 Europe Companion Diagnostic Revenue by Country (2017-2028)
7.3.2 Germany Companion Diagnostic Market Size and Forecast (2017-2028)
7.3.3 France Companion Diagnostic Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Companion Diagnostic Market Size and Forecast (2017-2028)
7.3.5 Russia Companion Diagnostic Market Size and Forecast (2017-2028)
7.3.6 Italy Companion Diagnostic Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Companion Diagnostic Revenue by Type (2017-2028)
8.2 Asia-Pacific Companion Diagnostic Revenue by Application (2017-2028)
8.3 Asia-Pacific Companion Diagnostic Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostic Revenue by Region (2017-2028)
8.3.2 China Companion Diagnostic Market Size and Forecast (2017-2028)
8.3.3 Japan Companion Diagnostic Market Size and Forecast (2017-2028)
8.3.4 South Korea Companion Diagnostic Market Size and Forecast (2017-2028)
8.3.5 India Companion Diagnostic Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Companion Diagnostic Market Size and Forecast (2017-2028)
8.3.7 Australia Companion Diagnostic Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Companion Diagnostic Revenue by Type (2017-2028)
9.2 South America Companion Diagnostic Revenue by Application (2017-2028)
9.3 South America Companion Diagnostic Market Size by Country
9.3.1 South America Companion Diagnostic Revenue by Country (2017-2028)
9.3.2 Brazil Companion Diagnostic Market Size and Forecast (2017-2028)
9.3.3 Argentina Companion Diagnostic Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Companion Diagnostic Revenue by Type (2017-2028)
10.2 Middle East & Africa Companion Diagnostic Revenue by Application (2017-2028)
10.3 Middle East & Africa Companion Diagnostic Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostic Revenue by Country (2017-2028)
10.3.2 Turkey Companion Diagnostic Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Companion Diagnostic Market Size and Forecast (2017-2028)
10.3.4 UAE Companion Diagnostic Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Companion Diagnostic Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Companion Diagnostic Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Companion Diagnostic Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Companion Diagnostic Revenue (USD Million) by Region (2017-2022)
Table 5. Global Companion Diagnostic Revenue Market Share by Region (2023-2028)
Table 6. Roche Holdings Corporate Information, Head Office, and Major Competitors
Table 7. Roche Holdings Major Business
Table 8. Roche Holdings Companion Diagnostic Product and Solutions
Table 9. Roche Holdings Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Companion Diagnostic Product and Solutions
Table 13. Abbott Laboratories Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Scientific Major Business
Table 16. Thermo Fisher Scientific Companion Diagnostic Product and Solutions
Table 17. Thermo Fisher Scientific Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies Major Business
Table 20. Agilent Technologies Companion Diagnostic Product and Solutions
Table 21. Agilent Technologies Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Merck Corporate Information, Head Office, and Major Competitors
Table 23. Merck Major Business
Table 24. Merck Companion Diagnostic Product and Solutions
Table 25. Merck Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Agendia Corporate Information, Head Office, and Major Competitors
Table 27. Agendia Major Business
Table 28. Agendia Companion Diagnostic Product and Solutions
Table 29. Agendia Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Qiagen Corporate Information, Head Office, and Major Competitors
Table 31. Qiagen Major Business
Table 32. Qiagen Companion Diagnostic Product and Solutions
Table 33. Qiagen Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 35. Myriad Genetics Major Business
Table 36. Myriad Genetics Companion Diagnostic Product and Solutions
Table 37. Myriad Genetics Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Advanced Cell Diagnostics Corporate Information, Head Office, and Major Competitors
Table 39. Advanced Cell Diagnostics Major Business
Table 40. Advanced Cell Diagnostics Companion Diagnostic Product and Solutions
Table 41. Advanced Cell Diagnostics Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Danaher Corporate Information, Head Office, and Major Competitors
Table 43. Danaher Major Business
Table 44. Danaher Companion Diagnostic Product and Solutions
Table 45. Danaher Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Illumina, Inc Corporate Information, Head Office, and Major Competitors
Table 47. Illumina, Inc Major Business
Table 48. Illumina, Inc Companion Diagnostic Product and Solutions
Table 49. Illumina, Inc Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global Companion Diagnostic Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global Companion Diagnostic Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of Companion Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Companion Diagnostic Players Head Office, Products and Services Provided
Table 54. Companion Diagnostic Mergers & Acquisitions in the Past Five Years
Table 55. Companion Diagnostic New Entrants and Expansion Plans
Table 56. Global Companion Diagnostic Revenue (USD Million) by Type (2017-2022)
Table 57. Global Companion Diagnostic Revenue Share by Type (2017-2022)
Table 58. Global Companion Diagnostic Revenue Forecast by Type (2023-2028)
Table 59. Global Companion Diagnostic Revenue by Application (2017-2022)
Table 60. Global Companion Diagnostic Revenue Forecast by Application (2023-2028)
Table 61. North America Companion Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 62. North America Companion Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 63. North America Companion Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 64. North America Companion Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 65. North America Companion Diagnostic Revenue by Country (2017-2022) & (USD Million)
Table 66. North America Companion Diagnostic Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe Companion Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe Companion Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe Companion Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe Companion Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe Companion Diagnostic Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe Companion Diagnostic Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific Companion Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific Companion Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific Companion Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific Companion Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific Companion Diagnostic Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific Companion Diagnostic Revenue by Region (2023-2028) & (USD Million)
Table 79. South America Companion Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 80. South America Companion Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 81. South America Companion Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 82. South America Companion Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 83. South America Companion Diagnostic Revenue by Country (2017-2022) & (USD Million)
Table 84. South America Companion Diagnostic Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa Companion Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa Companion Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa Companion Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa Companion Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa Companion Diagnostic Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa Companion Diagnostic Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Companion Diagnostic Picture
Figure 2. Global Companion Diagnostic Revenue Market Share by Type in 2021
Figure 3. Immunohistochemistry
Figure 4. Molecular Diagnosis
Figure 5. Companion Diagnostic Revenue Market Share by Application in 2021
Figure 6. Oncology Picture
Figure 7. Cardiovascular Picture
Figure 8. Central Nervous System Picture
Figure 9. Virology Picture
Figure 10. Others Picture
Figure 11. Global Companion Diagnostic Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Companion Diagnostic Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Companion Diagnostic Revenue Market Share by Region (2017-2028)
Figure 14. Global Companion Diagnostic Revenue Market Share by Region in 2021
Figure 15. North America Companion Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Companion Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Companion Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Companion Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Companion Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Companion Diagnostic Market Drivers
Figure 21. Companion Diagnostic Market Restraints
Figure 22. Companion Diagnostic Market Trends
Figure 23. Roche Holdings Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 26. Agilent Technologies Recent Developments and Future Plans
Figure 27. Merck Recent Developments and Future Plans
Figure 28. Agendia Recent Developments and Future Plans
Figure 29. Qiagen Recent Developments and Future Plans
Figure 30. Myriad Genetics Recent Developments and Future Plans
Figure 31. Advanced Cell Diagnostics Recent Developments and Future Plans
Figure 32. Danaher Recent Developments and Future Plans
Figure 33. Illumina, Inc Recent Developments and Future Plans
Figure 34. Global Companion Diagnostic Revenue Share by Players in 2021
Figure 35. Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Companion Diagnostic Revenue Market Share in 2021
Figure 37. Global Top 10 Players Companion Diagnostic Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Companion Diagnostic Revenue Share by Type in 2021
Figure 40. Global Companion Diagnostic Market Share Forecast by Type (2023-2028)
Figure 41. Global Companion Diagnostic Revenue Share by Application in 2021
Figure 42. Global Companion Diagnostic Market Share Forecast by Application (2023-2028)
Figure 43. North America Companion Diagnostic Sales Market Share by Type (2017-2028)
Figure 44. North America Companion Diagnostic Sales Market Share by Application (2017-2028)
Figure 45. North America Companion Diagnostic Revenue Market Share by Country (2017-2028)
Figure 46. United States Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Companion Diagnostic Sales Market Share by Type (2017-2028)
Figure 50. Europe Companion Diagnostic Sales Market Share by Application (2017-2028)
Figure 51. Europe Companion Diagnostic Revenue Market Share by Country (2017-2028)
Figure 52. Germany Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Companion Diagnostic Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Companion Diagnostic Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Companion Diagnostic Revenue Market Share by Region (2017-2028)
Figure 60. China Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Companion Diagnostic Sales Market Share by Type (2017-2028)
Figure 67. South America Companion Diagnostic Sales Market Share by Application (2017-2028)
Figure 68. South America Companion Diagnostic Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Companion Diagnostic Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Companion Diagnostic Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Companion Diagnostic Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Companion Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
